Appointment booking for Tara Leblanc, OTR/L, MOT is currently not available.Tara Leblanc, OTR/L, MOT has not yet fully activated their profile on DiabetesIQ.
Tara Leblanc, OTR/L, MOT (she/her) is a Occupational Therapist in Baton Rouge, LA with over 15 years of experience. What is your opinion of Tara Leblanc, OTR/L, MOT? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 15 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Tara Leblanc, OTR/L, MOT has received over $1,885 which includes payments from the following companies:
$668.88 from Alcon Laboratories Inc
$306.73 from Allergan Inc.
$284.52 from Shire North American Group Inc
$169.87 from Johnson & Johnson Vision Care, Inc.
$128.21 from Regeneron Pharmaceuticals, Inc.
$118.21 from Johnson & Johnson Surgical Vision, Inc.
$112.26 from CooperVision Inc.
$35.61 from Valeant Pharmaceuticals North America LLC
$24.70 from Carl Zeiss Meditec, Inc.
$19.59 from Eyevance Pharmaceuticals LLC
$16.68 from GLAUKOS CORPORATION
Payments received by Tara Leblanc, OTR/L, MOT were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!
Benefits of Occupational Therapy for People with DiabetesDiabetes affects approximately 23.6 million people in the United States. Even though complications from type 1 or type 2 diabetes can be prevented through self-management, maintaining control of the disease can be difficult and negatively affect the quality of life for patients of all...